Latest data from September 24, 2021
Number of Health Center respondents = 43 (91% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 20,645 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 62.30% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 2,405 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 61.89% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 33.83% | 34.30% |
| White, Hispanic/Latino Patients | 18.50% | 16.63% |
| Black/African American, Non-Hispanic/Latino Patients | 26.33% | 26.32% |
| Black/African American, Hispanic/Latino Patients | 0.83% | 0.58% |
| Asian Patients3 | 1.15% | 0.58% |
| American Indian/Alaska Native Patients3 | 0.56% | 0.54% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.30% | 0.25% |
| Patients with More than one race3 | 3.36% | 4.07% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 4.88% | 6.74% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 2.33% | 1.66% |
| Unreported/Refused to Report Race and Ethnicity | 7.94% | 8.32% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 3,783 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 83.58% |
| COVID-19 Immunization Series Completed | 4,480 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 82.10% |
| COVID-19 Immunization Series Additional | 1,469 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 49.18% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 15.49% | 16.88% | 48.60% |
| White, Hispanic/Latino Patients | 29.90% | 30.80% | 6.40% |
| Black/African American, Non-Hispanic/Latino Patients | 36.82% | 33.37% | 31.04% |
| Black/African American, Hispanic/Latino Patients | 1.22% | 0.98% | 1.63% |
| Asian Patients3 | 0.77% | 0.69% | 4.90% |
| American Indian/Alaska Native Patients3 | 0.95% | 1.76% | 0.34% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.40% | 0.42% | 0.27% |
| Patients with More than one race3 | 3.15% | 2.83% | 2.31% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 5.63% | 6.52% | 0.14% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 1.93% | 1.70% | 0.95% |
| Unreported/Refused to Report Race and Ethnicity | 3.75% | 4.04% | 3.40% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 25.58% |
| 1 to 24 Hours | 18.60% |
| More Than 24 Hours | 55.81% |
| N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 9.30% |
| Staffing to administer the vaccine | 30.23% |
| Vaccine confidence | 46.51% |
| Vaccine storage capacity | 2.33% |
| Vaccine supply | 2.33% |
| Other | 4.65% |
| None | 27.91% |
Operations and Staff
| Metrics | Value |
|---|---|
| Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits | 95.35% |
| Average Percent of Health Center Visits Conducted Virtually | 13.60% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 41.86% |
| Number of Mobile Van Sites | 68 |
| Number of Pop-up Clinics | 42 |
| Number of School-Based Vaccination Sites | 4 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 11.63% |
| Refer patients to another organization that provides monoclonal antibody therapies | 30.23% |
| None | 58.14% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 9.30% |
| Patient awareness/education | 6.98% |
| Staffing capacity | 30.23% |
| Therapy administration/onsite logistics | 16.28% |
| Other | 11.63% |
| None | 41.86% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
